Results 141 to 150 of about 25,866 (210)

Transient intracranial imaging features on MRI following intra-arterial chemotherapy for intraocular and orbital malignancies. [PDF]

Interv Neuroradiol
Parks SM, Suribhatla Y, Beser BG, Wilseck ZM, Demirci H, Chaudhary N.   +5 more
europepmc   +1 more source

Integration of exosome-related genes and differential expression analysis reveals potential biomarkers for prostate cancer. [PDF]

Discov Oncol
Huang S, Hu C, Guo Z, Zhang X, Wu T, Zeng Y, Qing C, Cheng S.   +7 more
europepmc   +1 more source

Cost effectiveness and pricing strategy of first line benmelstobart combination treatment for extensive stage small cell lung cancer in China. [PDF]

Sci Rep
Zhao S, Kang S.
europepmc   +1 more source

KSQ-4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1-Mediated Multidrug Resistant Cancers. [PDF]

MedComm (2020)
Yang Q, Luo K, To KKW, Pan C, Fu K, Zhu S, Li S, Wang F, Wu C, Fu L.   +9 more
europepmc   +1 more source

Update on Retinoblastoma Therapies. [PDF]

Medicina (Kaunas)
Martínez Arce CA, Villegas VM, Di Nicola M, Williams BK, Murray TG.   +4 more
europepmc   +1 more source

Impact of carboplatin desensitization therapy on progression-free survival in gynecologic cancers. [PDF]

Gynecol Oncol Rep
Bastin N, Petrie H, Robinson M, Javid A, Lane R, Boucher T, Brown AJ, Prescott LS, Phillips E, Alvarez RD, Crispens M, Stone CA.   +11 more
europepmc   +1 more source

A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and Outcomes. [PDF]

Clin Epidemiol
Pundole X, Younan D, Critchlow CW, Puntis SR, Soohoo M, Anderson ES, Najdi R, Horinouchi H, Calvo V, Cobo M, Lopez-Castro R, Bernabe R, Cho J, Desai PA, Ahn MJ, Provencio M.   +15 more
europepmc   +1 more source

Cost-effectiveness of chemotherapy for advanced and recurrent cervical cancer: a systematic review. [PDF]

Front Health Serv
Inami K.
europepmc   +1 more source

Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDAC. [PDF]

Pancreas
Thiel V, Nadler WM, Kerner A, Kuhlmann L, Reitberger M, Vorberg T, Schwerd-Kleine P, Noll E, Giese NA, Yen HY, Steiger K, Vogel V, Klein C, Hackert T, Koschny R, Opitz CA, Trumpp A, Sprick MR, Rösli C.   +18 more
europepmc   +1 more source

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† [PDF]

, 2017
Crinò, L., De Ruysscher, D., Felip, E., Früh, M., Peters, S., Popat, S.   +5 more
core